News from SGC

Posted on Thursday 3rd of November 2016

Bromodomains (BRDs) have emerged as compelling targets for cancer therapy, however the complex multidomain/subunit architecture of BRD-protein complexes complicates predictions of consequences of their pharmacological targeting

Posted on Friday 7th of October 2016

Pioneering work to accelerate drug discovery earned the SGC the 2016 Oxford Academic Health Science Network (Oxford AHSN) collaboration award.

Posted on Monday 12th of September 2016

Target-enabling packages provide a crucial link between human genetics and disease biology to accelerate drug discovery in cancer and malaria

Posted on Friday 5th of August 2016

A groundbreaking partnership between the Alzheimer’s Research UK Drug Discovery Alliance (DDA) and the Structural Genomics Consortium (SGC), an international group of academic and industrial researchers with a strong track record in uncovering new drug targets and enabling new clinical trials, quickly.

Posted on Friday 1st of July 2016

An updated version of The Chemical Probes Portal is now live with new content, including a lot more data about the existing probes, reviewer ratings and their comments.

Posted on Wednesday 18th of May 2016

For a second year, SGC Toronto hosted a team of senior law students from the University of Toronto's Faculty of Law as part of an externship clinic to help SGC draft new agreements protecting our open access ethos and promoting our open science.

Posted on Saturday 23rd of April 2016

FOP patient groups have announced an extension of their support to the FOP research team in SGC Oxford led by Dr Alex Bullock since 2008. The team, currently comprising two postdoctoral fellows, is working towards developing a treatment for the rare monogenic disease Fibrodysplasia Ossificans Progressiva (FOP), a disorder that causes severely debilitating extraskeletal bone formation and impairs movement.

Posted on Wednesday 13th of April 2016

We are delighted to announce a groundbreaking partnership between The Brain Tumour Charity and the Structural Genomics Consortium (SGC), an international group of academic and industrial researchers with a strong track record in uncovering new drug targets and initiating clinical trials within unusually short timeframes.

Posted on Wednesday 6th of April 2016

An exhibition of work produced by students of the Arts University Bournemouth in collaboration with the SGC

Posted on Tuesday 5th of April 2016

Registration is now open for the Joint Malaria Symposium: “Science and policy shield the vulnerable from malaria”. The symposium will be held on Monday, 20 June 2016, at McGill University in Montreal, Quebec, Canada from 9am-1pm.

Pages

Subscribe to News from SGC
glqxz9283 sfy39587stf02 mnesdcuix8
sfy39587stf03